Security key
61225M102
Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE)
CUSIP: 61225M102
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 41,325,746
- Total 13F value
- $314,458,629
- Share change
- +972,645
- Put/Call ratio
- 2.6%
- SEC-reported price per share
- $7.61
- Number of holders
- 66
- Value change
- +$7,213,706
- Number of buys
- 31
- Number of sells
- 27
- Shares outstanding
- 84,393,162
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
66
Top holders
10
GLUE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Monte Rosa Therapeutics, Inc. SEC filings
Monte Rosa Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61225M102
Recent filing periods:
Ownership snapshot
Top reported holders of GLUE - Monte Rosa Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
NEA Management Company, LLC
Disclosed value leader
NEA Management Company, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
3/4/5
Lead comparable stake: 9.1%
Showing 1-6 of 15 holder rows.
Quick read
NEA Management Company, LLC leads the comparable SEC ownership view at 9.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens NEA Management Company, LLC's linked filing trail.
Comparable ownership
Top 5
NEA Management Company, LLC
9.1%
FMR LLC
7.4%
PRICE T ROWE ASSOCIATES INC /MD/
4.5%
BlackRock Finance, Inc.
4.1%
Avoro Capital Advisors LLC
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
Company
|
9.1%
|
$62,935,000
7,703,205 shares
|
— | 30 Sep 2022 |
| FMR LLC |
13F
Company
|
7.4%
|
$50,695,000
6,204,974 shares
|
— | 30 Sep 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.5%
|
$30,747,000
3,763,386 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.1%
|
$28,352,000
3,470,232 shares
|
— | 30 Sep 2022 |
| Avoro Capital Advisors LLC |
13F
Company
|
4%
|
$27,478,000
3,363,333 shares
|
— | 30 Sep 2022 |
| Cormorant Asset Management, LP |
3/4/5
13F
Former 10% Owner · Company
|
3.5%
from 13F
|
$60,841,800
3,202,200 shares
|
— | 28 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
41,325,746
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
70
Q4 2022 holders
66
Holder diff
-4
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend